BMS 299897 | MedChemExpress (MCE)
品牌 | 厂商性质 | 产地 | 货期 | 价格 |
---|---|---|---|---|
MedChemExpress (MCE) | 生产商 | 美国 | 现货 | 957 |
性能特点
BMS 299897 是一种磺胺类γ-secretase 抑制剂,作用于稳定过表达淀粉样前体蛋白 (APP) 的HEK293 细胞,抑制Aβ产生,IC50 为 7 nM。
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mM * 1 mL | 290315-45-6 | ¥957.00 | 询底价 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
BMS 299897
CAS No. : 290315-45-6
MCE 国际站:BMS 299897
产品活性:BMS 299897 是一种磺胺类γ-secretase 抑制剂,作用于稳定过表达淀粉样前体蛋白 (APP) 的HEK293 细胞,抑制Aβ产生,IC50 为 7 nM。
研究领域:Neuronal Signaling | Stem Cell/Wnt
作用靶点:γ-secretase
In Vitro: BMS-299897 reduces the levels of each of the Aβ peptides. At 1 μM, BMS-299897 decreases these peptides to levels ranging from 20 to 50% of the vehicle control. BMS-299897 treatment reduces the portion of QD-BDNF signals moving in the retrograde direction (p=0.0198) with a concomitant increase in the portion of signals moving in the anterograde direction (p=0.0147).
In Vivo: BMS-299897 shows dose- and time-dependent reductions of amyloid β-peptide (Aβ) in brain, cerebrospinal fluid (CSF), and plasma in young transgenic mice, with a correlation between brain and CSF Aβ levels. BMS-299897 reduces both brain and plasma Aβ1-40 in APP-YAC mice and increases brain concentrations of APPcarboxy-terminal fragments, consistent with γ-secretase inhibition. BMS-299897, attenuates this Aβ25-35-induced Aβ1-42 seeding and toxicity. BMS-299897 is administered at 0.1-1 nmol/mouse, concomittantly with Aβ25-35 (9 nmol) in male Swiss mice. After one week, the contents in Aβ1-42 and Aβ1-40, and the levels in lipid peroxidation are analyzed in the mouse hippocampus. Mice are submitted to spontaneous alternation, passive avoidance and object recognition to analyze their short- and long-term memory abilities. Aβ25-35 increases Aβ1-42 content (+240%) but fails to affect Aβ1-40. BMS-299897 blocks the increase in Aβ1-42 content and decreased Aβ1-40 levels significantly. The compound does not affect Aβ25-35-induced increase in hippocampal lipid peroxidation. Behaviorally, BMS-299897 blocks the Aβ25-35-induced deficits in spontaneous alternation or novel object recognition, using a 1 h intertrial time interval. The co-administration of the γ-secretase inhibitor BMS-299897, in the 0.1-1 μmol/mouse dose-range, completely blocks the Aβ25-35-induced increase in Aβ1-42 content.
相关产品:Natural Product-like Compound Library | Bioactive Compound Library Plus | Neuronal Signaling Compound Library | Stem Cell Signaling Compound Library | CNS-Penetrant Compound Library | Anti-Aging Compound Library | Differentiation Inducing Compound Library | Reprogramming Compound Library | Ferroptosis Compound Library | Neurodegenerative Disease-related Compound Library | Cancer Stem Cells Compound Library | Membrane Protein-targeted Compound Library | DAPT | LY-411575 | Compound E | Nirogacestat | YO-01027 | RO4929097 | Crenigacestat | Semagacestat | MK-0752 | L-685458 | BMS-906024 | E 2012 | Sulindac sulfide | Avagacestat | BPN-15606 | MRK-560 | PF-06648671 | LY900009 | Fosciclopirox | SPL-707 | Z-Ile-Leu-aldehyde | Begacestat | Itanapraced | NGP555 | ELN318463 | gamma-secretase modulator 1 hydrochloride | Aβ42-IN-2 | gamma-secretase modulator 2 | GSM-1 | JNJ-40418677
热门产品线:重组蛋白 | 药物筛选 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
品牌介绍:
• MCE (MedChemExpress) 拥有200 多种全球独家化合物库,我们致力于为全球科研客户提供前沿最全的高品质小分子活性化合物;
• 50,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域;
• 产品种类涵盖各种重组蛋白,多肽,常用试剂盒 ,更有 PROTAC、ADC 等特色产品,广泛应用于新药研发、生命科学等科研项目;
• 提供虚拟筛选,离子通道筛选,代谢组学分析检测分析,药物筛选等专业技术服务;
• 设有专业的实验中心和严格的质控、验证体系;
• 提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告,确保产品的高纯度、高品质;
• 产品的生物活性多经各国客户实验验证;
• Nature, Cell, Science 等多种顶级期刊及制药专利收录了MCE客户的科研成果;
• 专业团队跟踪最新的制药及生命科学研究进展,为您提供全球最新的活性化合物;
• 与世界各大制药公司及知名科研机构建立了长期的合作。
![MCE Hotline: 4008203792 | 中国现货 - 全球文献引用 - 高纯度高品质 - 全方位技术支持](https://file.medchemexpress.cn/web-groups/product-type/7.jpg)
BMS 299897 | MedChemExpress (MCE)信息由MedChemExpress (MCE)为您提供,如您想了解更多关于BMS 299897 | MedChemExpress (MCE)报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途